
News|Articles|March 4, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of March 4, 2022
Author(s)Sydney Jennings
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Advertisement
How many fully vaccinated Americans have received a booster dose?
According to the Centers for Disease Control and Prevention (CDC) as of today, March 4, 2022, at 2:40 PM, EDT:
44% of fully vaccinated persons in the US have received a booster dose of COVID-19 vaccine.
What percentage of people across age groups in the US have been fully vaccinated?
According to the CDC as of today, March 4, 2022, at 2:40 PM, EDT:
• 65.1% of total US population
• 69.2% of US population aged ≥5 years
• 73.5% of US population aged ≥12 years
• 75.1% of US population aged ≥18 years
• 88.8% of US population aged ≥65 years
The 5 states/territories with the highest percentage of population fully vaccinated are:
1. Puerto Rico: 81.7%
2. Rhode Island: 80.8%
3. Vermont: 80.2%
4. Maine: 78.5%
5. Connecticut: 77.9%
2. Rhode Island: 80.8%
3. Vermont: 80.2%
4. Maine: 78.5%
5. Connecticut: 77.9%
How many cases of COVID-19 have been confirmed in the US?
According to the Johns Hopkins COVID-19 interactive map , as of today, March 4, 2022 at 4:21 PM, EDT, there have been:
• 79 232 260 confirmed cases and
• 957 633 deaths
• 957 633 deaths
The 5 states with the highest total confirmed cases are:
1. California: 9 002 681
2. Texas: 6 634 375
3. Florida: 5 844 096
4. New York: 4 931 337
5. Illinois: 3 037 199
2. Texas: 6 634 375
3. Florida: 5 844 096
4. New York: 4 931 337
5. Illinois: 3 037 199
Deaths: California has the highest number of deaths due to COVID-19 with 86 155 reported fatalities, followed by Texas with 85 598 and Florida with 70 789.
How many cases of COVID-19 have been confirmed globally?
Globally, there have been 443 000 936 confirmed cases, 5 988 000 deaths, and 10 565 300 777 vaccine doses administered.
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.
Advertisement
Advertisement
Advertisement
Trending on Patient Care Online
1
Lilly's Novel Oral GLP-1 Orforglipron Shows Superior Efficacy in 2 Phase 3 Trials
2
FDA OKs Subcutaneous Guselkumab Regimen for Ulcerative Colitis: Daily Dose
3
"Shared Decision-Making" for COVID-19 Vaccination Signals "Optional" to Too Many, Says Kelly Moore, MD, MPH
4
FDA Approves Updated Indication Statement for Upadacitinib in Inflammatory Bowel Disease Treatment
5